Nu Skin Enterprises trades at a deep value multiple (~3x 2026 EBITDA) but faces persistent core business decline and unproven turnaround catalysts. Guidance disappointed, yet management expects margin ...

Nu Skin is rated a buy, trading at low multiples with turnaround prospects tied to India expansion and Prysm iO device launch. NUS’s core MLM business faces structural decline, but new product and ...

Nu Skin Enterprises, Inc. NUS is likely to register a decline in the top and bottom lines when it reports fourth-quarter 2024 earnings on Feb. 13. The Zacks Consensus Estimate for revenues is pegged ...

Nu Skin Enterprises, Inc. NUS is likely to register declines in the top and bottom lines when it reports fourth-quarter 2025 earnings on Feb. 12, after market close. The Zacks Consensus Estimate for ...

Nu Skin Enterprises, Inc. (NYSE:NUS) saw its shares rise on Friday following the announcement of a strategic transaction by its Rhyz Inc. subsidiary. Rhyz has sold its Mavely affiliate marketing ...

We recently published a list of the 12 Best Household Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Nu Skin Enterprises, Inc. (NYSE:NUS) stands against ...

We recently published a list of 12 Best Cosmetics Stocks to Buy for 2025. In this article, we are going to take a look at where Nu Skin Enterprises, Inc. (NYSE:NUS) stands against other best cosmetics ...

Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue at the high end of its guidance range. Executive Summary Q1 2025 vs. Prior-year Qu ...

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced MYND360, a new line of clinically proven nutritional formulas to support core needs ...